Literature DB >> 9106193

Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1.

D R Cavanagh1, J S McBride.   

Abstract

We have expressed seven recombinant antigens representing two N-terminal regions of the polymorphic merozoite surface protein 1 (MSP-1) of Plasmodium falciparum. The antigens include the MAD20 and Palo Alto forms of the relatively conserved Block 1 region, and variants of the Block 2 region from isolates 3D7, Palo Alto FUP, MAD20, Wellcome and RO33, that are representative of a range or amino acid sequence diversity in this most polymorphic section of MSP-1. All recombinant antigens have been able to immunise mice to produce polyclonal antibodies which specifically recognise parasite MSP-1 in indirect immunofluorescence assays and in Western blots. The recombinant antigens also react appropriately in ELISA with murine monoclonal antibodies specific for variant epitopes in Block 2 of MSP-1. These results show that the antigenic structure of the recombinant proteins is similar to that of the native MSP-1 product from parasites. Importantly, human sera from malaria-exposed individuals contain IgG antibodies that recognise very specifically one or another of the Block 2 types, showing that different Block 2 types are immunogenic, antigenically distinct and distinguishable when presented during natural infections. In contrast, the conserved Block 1 is rarely recognised by human antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106193     DOI: 10.1016/s0166-6851(96)02826-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  29 in total

1.  Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.

Authors:  D R Cavanagh; C Dobaño; I M Elhassan; K Marsh; A Elhassan; L Hviid; E A Khalil; T G Theander; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Extensive antigenic polymorphism within the repeat sequence of the Plasmodium falciparum merozoite surface protein 1 block 2 is incorporated in a minimal polyvalent immunogen.

Authors:  Kevin K A Tetteh; David R Cavanagh; Patrick Corran; Rosemary Musonda; Jana S McBride; David J Conway
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Expression of merozoite surface protein markers by Plasmodium falciparum-infected erythrocytes in peripheral blood and tissues of children with fatal malaria.

Authors:  Carlota Dobaño; Stephen J Rogerson; Terrie E Taylor; Jana S McBride; Malcolm E Molyneux
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 4.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.

Authors:  Kézia K G Scopel; Cor J F Fontes; Marcelo U Ferreira; Erika M Braga
Journal:  Clin Vaccine Immunol       Date:  2006-07

6.  A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.

Authors:  Paulo Afonso Nogueira; Fabiana Piovesan Alves; Carmen Fernandez-Becerra; Oliver Pein; Neida Rodrigues Santos; Luiz Hildebrando Pereira da Silva; Erney Plessman Camargo; Hernando A del Portillo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes.

Authors:  John P A Lusingu; Anja T R Jensen; Lasse S Vestergaard; Daniel T Minja; Michael B Dalgaard; Samwel Gesase; Bruno P Mmbando; Andrew Y Kitua; Martha M Lemnge; David Cavanagh; Lars Hviid; Thor G Theander
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

8.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

9.  FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.

Authors:  Amre Nasr; Nnaemeka C Iriemenam; Hayder A Giha; Halima A Balogun; Robin F Anders; Marita Troye-Blomberg; Gehad ElGhazali; Klavs Berzins
Journal:  Malar J       Date:  2009-03-13       Impact factor: 2.979

10.  MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum.

Authors:  Elke S Bergmann-Leitner; Elizabeth H Duncan; Evelina Angov
Journal:  Malar J       Date:  2009-08-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.